vs

Side-by-side financial comparison of Hess Midstream LP (HESM) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

Hess Midstream LP is the larger business by last-quarter revenue ($204.1M vs $151.7M, roughly 1.3× Tarsus Pharmaceuticals, Inc.). Hess Midstream LP runs the higher net margin — 77.3% vs -5.5%, a 82.8% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 2.1%). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs -25.3%).

Hess Corporation is an American global independent energy company involved in the exploration and production of crude oil and natural gas. It was formed by the merger of Hess Oil and Chemical and Amerada Petroleum in 1968. Leon Hess was CEO from the early 1960s until 1995, after which his son John B Hess succeeded him as chairman and CEO. The company agreed to be acquired by rival oil company Chevron in October 2023, and the acquisition closed in July 2025.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

HESM vs TARS — Head-to-Head

Bigger by revenue
HESM
HESM
1.3× larger
HESM
$204.1M
$151.7M
TARS
Growing faster (revenue YoY)
TARS
TARS
+126.3% gap
TARS
128.4%
2.1%
HESM
Higher net margin
HESM
HESM
82.8% more per $
HESM
77.3%
-5.5%
TARS
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
-25.3%
HESM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
HESM
HESM
TARS
TARS
Revenue
$204.1M
$151.7M
Net Profit
$157.7M
$-8.4M
Gross Margin
Operating Margin
116.7%
-5.3%
Net Margin
77.3%
-5.5%
Revenue YoY
2.1%
128.4%
Net Profit YoY
-2.3%
63.8%
EPS (diluted)
$0.68
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HESM
HESM
TARS
TARS
Q1 26
$204.1M
Q4 25
$404.2M
$151.7M
Q3 25
$420.9M
$118.7M
Q2 25
$414.2M
$102.7M
Q1 25
$382.0M
$78.3M
Q4 24
$395.9M
$66.4M
Q3 24
$378.5M
$48.1M
Q2 24
$365.5M
$40.8M
Net Profit
HESM
HESM
TARS
TARS
Q1 26
$157.7M
Q4 25
$93.3M
$-8.4M
Q3 25
$97.7M
$-12.6M
Q2 25
$90.3M
$-20.3M
Q1 25
$71.6M
$-25.1M
Q4 24
$70.4M
$-23.1M
Q3 24
$58.6M
$-23.4M
Q2 24
$49.5M
$-33.3M
Operating Margin
HESM
HESM
TARS
TARS
Q1 26
116.7%
Q4 25
62.2%
-5.3%
Q3 25
61.5%
-12.2%
Q2 25
62.8%
-21.6%
Q1 25
62.1%
-33.5%
Q4 24
61.4%
-36.8%
Q3 24
61.2%
-52.3%
Q2 24
60.8%
-81.6%
Net Margin
HESM
HESM
TARS
TARS
Q1 26
77.3%
Q4 25
23.1%
-5.5%
Q3 25
23.2%
-10.6%
Q2 25
21.8%
-19.8%
Q1 25
18.7%
-32.1%
Q4 24
17.8%
-34.8%
Q3 24
15.5%
-48.7%
Q2 24
13.5%
-81.6%
EPS (diluted)
HESM
HESM
TARS
TARS
Q1 26
$0.68
Q4 25
$-0.17
Q3 25
$-0.30
Q2 25
$-0.48
Q1 25
$-0.64
Q4 24
$-0.57
Q3 24
$-0.61
Q2 24
$-0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HESM
HESM
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$417.3M
Total DebtLower is stronger
$72.4M
Stockholders' EquityBook value
$343.4M
Total Assets
$562.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HESM
HESM
TARS
TARS
Q1 26
Q4 25
$1.9M
$417.3M
Q3 25
$5.5M
$401.8M
Q2 25
$4.5M
$381.1M
Q1 25
$6.1M
$407.9M
Q4 24
$4.3M
$291.4M
Q3 24
$10.3M
$317.0M
Q2 24
$99.6M
$323.6M
Total Debt
HESM
HESM
TARS
TARS
Q1 26
Q4 25
$3.8B
$72.4M
Q3 25
$72.3M
Q2 25
$72.1M
Q1 25
$72.0M
Q4 24
$3.5B
$71.8M
Q3 24
$71.7M
Q2 24
$71.6M
Stockholders' Equity
HESM
HESM
TARS
TARS
Q1 26
Q4 25
$343.4M
Q3 25
$335.1M
Q2 25
$332.6M
Q1 25
$342.5M
Q4 24
$224.5M
Q3 24
$237.5M
Q2 24
$252.2M
Total Assets
HESM
HESM
TARS
TARS
Q1 26
Q4 25
$4.4B
$562.2M
Q3 25
$4.4B
$534.6M
Q2 25
$4.4B
$495.0M
Q1 25
$4.3B
$500.8M
Q4 24
$4.2B
$377.0M
Q3 24
$4.1B
$376.3M
Q2 24
$4.1B
$376.8M
Debt / Equity
HESM
HESM
TARS
TARS
Q1 26
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×
Q2 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HESM
HESM
TARS
TARS
Operating Cash FlowLast quarter
$253.3M
$19.3M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
8.6%
Capex IntensityCapex / Revenue
51.4%
4.2%
Cash ConversionOCF / Net Profit
1.61×
TTM Free Cash FlowTrailing 4 quarters
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HESM
HESM
TARS
TARS
Q1 26
$253.3M
Q4 25
$245.6M
$19.3M
Q3 25
$258.9M
$18.3M
Q2 25
$276.9M
$-29.4M
Q1 25
$202.4M
$-20.7M
Q4 24
$258.5M
$-22.2M
Q3 24
$224.9M
$-8.7M
Q2 24
$271.6M
$-14.4M
Free Cash Flow
HESM
HESM
TARS
TARS
Q1 26
Q4 25
$178.9M
$13.0M
Q3 25
$178.9M
$16.3M
Q2 25
$213.5M
$-30.4M
Q1 25
$156.9M
$-21.2M
Q4 24
$163.4M
$-22.3M
Q3 24
$132.6M
$-8.9M
Q2 24
$207.7M
$-15.4M
FCF Margin
HESM
HESM
TARS
TARS
Q1 26
Q4 25
44.3%
8.6%
Q3 25
42.5%
13.8%
Q2 25
51.5%
-29.6%
Q1 25
41.1%
-27.1%
Q4 24
41.3%
-33.5%
Q3 24
35.0%
-18.6%
Q2 24
56.8%
-37.8%
Capex Intensity
HESM
HESM
TARS
TARS
Q1 26
51.4%
Q4 25
16.5%
4.2%
Q3 25
19.0%
1.6%
Q2 25
15.3%
1.0%
Q1 25
11.9%
0.8%
Q4 24
24.0%
0.1%
Q3 24
24.4%
0.6%
Q2 24
17.5%
2.5%
Cash Conversion
HESM
HESM
TARS
TARS
Q1 26
1.61×
Q4 25
2.63×
Q3 25
2.65×
Q2 25
3.07×
Q1 25
2.83×
Q4 24
3.67×
Q3 24
3.84×
Q2 24
5.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HESM
HESM

Affiliate services$197.9M97%
Third-party services$6.2M3%

TARS
TARS

Segment breakdown not available.

Related Comparisons